about
Neglected infections of poverty in the United States of AmericaNovel amidines and analogues as promising agents against intracellular parasites: a systematic reviewDifferential Gel Electrophoresis (DIGE) Evaluation of Naphthoimidazoles Mode of Action: A Study in Trypanosoma cruzi Bloodstream TrypomastigotesIn vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruziIn vitro and in vivo biological effects of novel arylimidamide derivatives against Trypanosoma cruzi.New drugs for neglected infectious diseases: Chagas' disease.Regulatory T cells phenotype in different clinical forms of Chagas' diseaseImmunoregulatory networks in human Chagas disease.Trypanosoma cruzi-induced activation of functionally distinct αβ and γδ CD4- CD8- T cells in individuals with polar forms of Chagas' disease.Importance of nonenteric protozoan infections in immunocompromised people.Effects of exercise training on heart rate variability in Chagas heart disease.Low doses of simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-infected dogs.Trypanosoma cruzi infection and endothelin-1 cooperatively activate pathogenic inflammatory pathways in cardiomyocytes.Plasma cytokine expression is associated with cardiac morbidity in chagas disease.Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones.Clinical and epidemiological profile of elderly patients with Chagas disease followed between 2005-2013 by pharmaceutical care service in Ceará State, Northeastern Brazil.Health-related quality of life in patients with Chagas disease: a review of the evidence.Clinical aspects of Chagas disease and implications for novel therapies.Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses.Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease.Safety Profile of Nifurtimox and Treatment Interruption for Chronic Chagas Disease in Colombian AdultsHigh interleukin 17 expression is correlated with better cardiac function in human Chagas disease.Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile.Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.Current concepts in immunoregulation and pathology of human Chagas disease.Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas diseaseAssessment of Functional Capacity in Chagas Heart Disease by Incremental Shuttle Walk Test and its Relation to Quality-of-Life.Parasitic infections and myositis.Insights into the clinical and functional significance of cardiac autonomic dysfunction in Chagas disease.Diagnosis and management of Chagas disease and cardiomyopathy.Mortality prediction in Chagas heart disease.Canine Macrophage DH82 Cell Line As a Model to Study Susceptibility to Trypanosoma cruzi Infection.Participation of TLR2 and TLR4 in Cytokines Production by Patients with Symptomatic and Asymptomatic Chronic Chagas Disease.Synergic and antagonistic relationship between MMP-2 and MMP-9 with fibrosis and inflammation in Chagas' cardiomyopathy.Morbidity and prognostic factors in chronic chagasic cardiopathy.Biological, ultrastructural effect and subcellular localization of aromatic diamidines in Trypanosoma cruzi.Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease.Neuromuscular electrical stimulation in a patient with chronic heart failure due to chagas disease: a case report.The in vitro activity of fatty diamines and amino alcohols against mixed amastigote and trypomastigote Trypanosoma cruzi forms.Experimental and Clinical Treatment of Chagas Disease: A Review.
P2860
Q21144547-FC4CC350-8BB8-4924-A413-2C4A79E3C0EBQ26825025-3E4C6A51-5623-4004-A140-7DAA4D0669ACQ28553708-8BEEA510-262D-4CA5-AB7A-FAE8E717D9A2Q33798362-4AE57F80-5DED-4808-9DEC-28EB7B565122Q33798498-7050D0F1-11B6-46B4-921F-F1EC3908FA67Q33870393-D07496C1-5DCD-4FF2-AB79-CFE40B99C358Q33927456-76F39CE1-1BA0-4981-89FA-B5AD9535E5A4Q34084644-B830723C-CE6A-4966-991B-D73C657D8440Q34177376-509CD70D-7FD4-47D8-8BFE-79442D0F2B55Q34189873-8D51EF5A-19DD-4200-826F-58D9F30F07ACQ34319901-EA0B52AD-9C73-41C9-9141-6FE807696661Q34531351-15AA87E5-BB42-4F07-ADE0-E14BE79FA3AFQ34587039-80F830AF-7711-49E8-9ADA-F2DA17E072BAQ35112727-B1374B6F-2977-4CA0-8150-820F3D9DF249Q35367533-54EC0A1A-7CD7-4E13-8C45-15317208A1B5Q35617429-3379F8A8-44CB-4608-8CA0-D5B9B0E6DF77Q35636372-369EF609-491A-45E1-8450-40B90381D120Q35676177-9E30B9C2-D68F-4D1C-8022-B8FAE30B1F82Q36006382-FF67B855-FB14-4ADB-A399-B2D7FA7EED0FQ36258684-761AEB19-04A8-40A7-B417-6DD1A911802EQ36359270-8D64E95D-BBCA-44FC-BF37-2852161F5564Q36727275-C7E5E9BB-1810-46C6-91B4-34BEB941AB9DQ36883718-A4CE8B8C-43DD-42AA-A58C-4C079FBCDD24Q36904784-05706955-BD73-487D-822B-7746F454B696Q37151780-47A8452A-F605-43D7-BDAC-540C2F7F7C9AQ37264609-562E0461-FDD8-4FAB-9103-4308F12537B4Q37631907-0981F7EC-D3AA-4F17-B0F0-08AACB16198DQ37924643-77479685-35B5-4E7C-9542-BCA6D863A245Q38005593-3E028B9B-CEE5-4A3C-A0D0-A3BB411C8F39Q38030830-45E43E95-265B-440D-BA27-A63F1FF8CB80Q38055510-CB180E72-A432-4845-8B56-D9E87EB7E3D4Q38700140-1C9C69AE-CAFD-48FE-83CA-33745FA44EF7Q39244146-452AB3C8-8E4F-4D2B-8AA3-4237FED14342Q39329438-330604BA-AF62-4C22-AAE5-56D467CB229EQ39403291-C296A4D0-ABC2-4718-B378-3FEECFC880EFQ39945921-A54D9B2C-93A7-4A61-8407-3EF8A27B9C4BQ41485954-B1B128F1-932D-409F-97F3-74AA431C0DE3Q41846705-F93EDAD9-210A-430F-A49D-69064EDFE468Q41866298-AF76C6D8-FF91-43A4-A4E3-09476488CF15Q41989175-445069A4-D4CE-40E9-991D-37178A9612E4
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
An update on the management of Chagas cardiomyopathy.
@en
type
label
An update on the management of Chagas cardiomyopathy.
@en
prefLabel
An update on the management of Chagas cardiomyopathy.
@en
P2093
P2860
P356
P1476
An update on the management of Chagas cardiomyopathy.
@en
P2093
Antonio L Ribeiro
Manoel O C Rocha
Mauro M Teixeira
P2860
P304
P356
10.1586/14787210.5.4.727
P577
2007-08-01T00:00:00Z